Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Studies with interferon-alpha in human tumors.

S Einhorn, H Strander

    Medical Oncology and Tumor Pharmacotherapy
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of tissue and serum VEGF in patients with head and neck carcinoma.

    Angiogenesis·2003
    Same author

    Perceived symptoms and quality of life in women with breast cancer receiving radiation therapy.

    European journal of oncology nursing : the official journal of European Oncology Nursing Society·2003
    Same author

    Low levels of endostatin in the urine from patients with malignant disease.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2002
    Same author

    Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92.

    Leukemia·2002
    Same author

    Apoptosis and cell growth inhibition as antitumor effector functions of interferons.

    Medical oncology (Northwood, London, England)·2002
    Same author

    [Transcription map of the 13q14 region, frequently deleted in B-cell chronic lymphocytic leukemia patients].

    Genetika·2002

    Interferon-alpha (IFN-alpha) has shown promise in treating benign tumors like juvenile laryngeal papillomatosis. However, current evidence does not support its superiority over conventional treatments for malignant tumors.

    Area of Science:

    • Oncology
    • Immunology
    • Virology

    Background:

    • Clinical trials investigating Interferon-alpha (IFN-alpha) have been conducted since 1969.
    • IFN-alpha is derived from leukocyte buffy coats.
    • Research has explored IFN-alpha's efficacy across various benign and malignant tumor types.

    Purpose of the Study:

    • To evaluate the therapeutic potential of IFN-alpha in treating different tumor diseases.
    • To compare the effectiveness of IFN-alpha with existing treatment modalities.

    Main Methods:

    • Long-term clinical trials involving IFN-alpha administration.
    • Comparative analysis of treatment outcomes for benign and malignant tumors.

    Main Results:

    Related Experiment Videos

  • IFN-alpha demonstrated efficacy in inducing tumor regressions in certain benign and malignant conditions.
  • IFN-alpha proved superior to other treatments for juvenile laryngeal papillomatosis.
  • No significant superiority of IFN-alpha over conventional treatments was observed in malignant tumors studied.

    • Conclusions:

    • IFN-alpha shows significant promise as a treatment for specific benign tumors.
    • Further research is needed to establish the role of IFN-alpha in managing malignant tumors effectively.